Gencurix Inc. (KOSDAQ:229000)
South Korea · Delayed Price · Currency is KRW 1,866.00
+14.00 (0.76%)
Sep 4, 2026, 3:30 PM KST
Gencurix Revenue
Gencurix had revenue of 1.44B KRW in the quarter ending September 30, 2024, with 50.03% growth. This brings the company's revenue in the last twelve months to 3.39B, up 25.69% year-over-year. In the year 2023, Gencurix had annual revenue of 2.60B with 1.60% growth.
Revenue (ttm)
3.39B
Revenue Growth
+25.69%
P/S Ratio
12.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
43.72B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.60B | 40.83M | 1.60% |
| Dec 31, 2022 | 2.56B | -487.46M | -16.00% |
| Dec 31, 2021 | 3.05B | 1.47B | 93.83% |
| Dec 31, 2020 | 1.57B | 1.44B | 1,050.64% |
| Dec 31, 2019 | 136.62M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 126.23B |
| Ray Co., Ltd. | 119.17B |
| LabGenomics | 77.64B |
| Humasis | 32.87B |
| T&R Biofab | 29.73B |
| Access Bio | 23.54B |
| HASS Corp. | 16.08B |
| Sugentech | 9.78B |